Self-administered Drugs Market - Global Outlook and Forecast 2022-2028

March 2022 | 75 pages | ID: SDDEAA8B0727EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Self-administered Drugs in global, including the following market information:

Global Self-administered Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Self-administered Drugs Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Self-administered Drugs companies in 2021 (%)

The global Self-administered Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injectable Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Self-administered Drugs include Abbott Laboratories, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Gilead Sciences and Antares Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Self-administered Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Self-administered Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Self-administered Drugs Market Segment Percentages, by Type, 2021 (%)

• Injectable Drugs
• Inhaled Drugs
• Transdermal Drugs

Global Self-administered Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Self-administered Drugs Market Segment Percentages, by Application, 2021 (%)

• Cardiovascular Diseases
• Diabetes
• Osteoporosis
• Pain Management
• Hormone Replacement
• Others

Global Self-administered Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Self-administered Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Self-administered Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Self-administered Drugs revenues share in global market, 2021 (%)

Key companies Self-administered Drugs sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Self-administered Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Bristol-Myers Squibb
• Novartis AG
• Eli Lilly and Company
• Gilead Sciences
• Antares Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Self-administered Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Self-administered Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SELF-ADMINISTERED DRUGS OVERALL MARKET SIZE

2.1 Global Self-administered Drugs Market Size: 2021 VS 2028
2.2 Global Self-administered Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Self-administered Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Self-administered Drugs Players in Global Market
3.2 Top Global Self-administered Drugs Companies Ranked by Revenue
3.3 Global Self-administered Drugs Revenue by Companies
3.4 Global Self-administered Drugs Sales by Companies
3.5 Global Self-administered Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Self-administered Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Self-administered Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Self-administered Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Self-administered Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Self-administered Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Self-administered Drugs Market Size Markets, 2021 & 2028
  4.1.2 Injectable Drugs
  4.1.3 Inhaled Drugs
  4.1.4 Transdermal Drugs
4.2 By Type - Global Self-administered Drugs Revenue & Forecasts
  4.2.1 By Type - Global Self-administered Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Self-administered Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Self-administered Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Self-administered Drugs Sales & Forecasts
  4.3.1 By Type - Global Self-administered Drugs Sales, 2017-2022
  4.3.2 By Type - Global Self-administered Drugs Sales, 2023-2028
  4.3.3 By Type - Global Self-administered Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Self-administered Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Self-administered Drugs Market Size, 2021 & 2028
  5.1.2 Cardiovascular Diseases
  5.1.3 Diabetes
  5.1.4 Osteoporosis
  5.1.5 Pain Management
  5.1.6 Hormone Replacement
  5.1.7 Others
5.2 By Application - Global Self-administered Drugs Revenue & Forecasts
  5.2.1 By Application - Global Self-administered Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Self-administered Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Self-administered Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Self-administered Drugs Sales & Forecasts
  5.3.1 By Application - Global Self-administered Drugs Sales, 2017-2022
  5.3.2 By Application - Global Self-administered Drugs Sales, 2023-2028
  5.3.3 By Application - Global Self-administered Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Self-administered Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Self-administered Drugs Market Size, 2021 & 2028
6.2 By Region - Global Self-administered Drugs Revenue & Forecasts
  6.2.1 By Region - Global Self-administered Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Self-administered Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Self-administered Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Self-administered Drugs Sales & Forecasts
  6.3.1 By Region - Global Self-administered Drugs Sales, 2017-2022
  6.3.2 By Region - Global Self-administered Drugs Sales, 2023-2028
  6.3.3 By Region - Global Self-administered Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Self-administered Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Self-administered Drugs Sales, 2017-2028
  6.4.3 US Self-administered Drugs Market Size, 2017-2028
  6.4.4 Canada Self-administered Drugs Market Size, 2017-2028
  6.4.5 Mexico Self-administered Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Self-administered Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Self-administered Drugs Sales, 2017-2028
  6.5.3 Germany Self-administered Drugs Market Size, 2017-2028
  6.5.4 France Self-administered Drugs Market Size, 2017-2028
  6.5.5 U.K. Self-administered Drugs Market Size, 2017-2028
  6.5.6 Italy Self-administered Drugs Market Size, 2017-2028
  6.5.7 Russia Self-administered Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Self-administered Drugs Market Size, 2017-2028
  6.5.9 Benelux Self-administered Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Self-administered Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Self-administered Drugs Sales, 2017-2028
  6.6.3 China Self-administered Drugs Market Size, 2017-2028
  6.6.4 Japan Self-administered Drugs Market Size, 2017-2028
  6.6.5 South Korea Self-administered Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Self-administered Drugs Market Size, 2017-2028
  6.6.7 India Self-administered Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Self-administered Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Self-administered Drugs Sales, 2017-2028
  6.7.3 Brazil Self-administered Drugs Market Size, 2017-2028
  6.7.4 Argentina Self-administered Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Self-administered Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Self-administered Drugs Sales, 2017-2028
  6.8.3 Turkey Self-administered Drugs Market Size, 2017-2028
  6.8.4 Israel Self-administered Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Self-administered Drugs Market Size, 2017-2028
  6.8.6 UAE Self-administered Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Self-administered Drugs Major Product Offerings
  7.1.4 Abbott Laboratories Self-administered Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Self-administered Drugs Major Product Offerings
  7.2.4 Bristol-Myers Squibb Self-administered Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Self-administered Drugs Major Product Offerings
  7.3.4 Novartis AG Self-administered Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Eli Lilly and Company
  7.4.1 Eli Lilly and Company Corporate Summary
  7.4.2 Eli Lilly and Company Business Overview
  7.4.3 Eli Lilly and Company Self-administered Drugs Major Product Offerings
  7.4.4 Eli Lilly and Company Self-administered Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Eli Lilly and Company Key News
7.5 Gilead Sciences
  7.5.1 Gilead Sciences Corporate Summary
  7.5.2 Gilead Sciences Business Overview
  7.5.3 Gilead Sciences Self-administered Drugs Major Product Offerings
  7.5.4 Gilead Sciences Self-administered Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Gilead Sciences Key News
7.6 Antares Pharma
  7.6.1 Antares Pharma Corporate Summary
  7.6.2 Antares Pharma Business Overview
  7.6.3 Antares Pharma Self-administered Drugs Major Product Offerings
  7.6.4 Antares Pharma Self-administered Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Antares Pharma Key News

8 GLOBAL SELF-ADMINISTERED DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Self-administered Drugs Production Capacity, 2017-2028
8.2 Self-administered Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Self-administered Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 SELF-ADMINISTERED DRUGS SUPPLY CHAIN ANALYSIS

10.1 Self-administered Drugs Industry Value Chain
10.2 Self-administered Drugs Upstream Market
10.3 Self-administered Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Self-administered Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Self-administered Drugs in Global Market
Table 2. Top Self-administered Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Self-administered Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Self-administered Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Self-administered Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Self-administered Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Self-administered Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Self-administered Drugs Product Type
Table 9. List of Global Tier 1 Self-administered Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Self-administered Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Self-administered Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Self-administered Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Self-administered Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Self-administered Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Self-administered Drugs Sales (K MT), 2023-2028
Table 16. By Application – Global Self-administered Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Self-administered Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Self-administered Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Self-administered Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Self-administered Drugs Sales (K MT), 2023-2028
Table 21. By Region – Global Self-administered Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Self-administered Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Self-administered Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Self-administered Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Self-administered Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Self-administered Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Self-administered Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Self-administered Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Self-administered Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Self-administered Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Self-administered Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Self-administered Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Self-administered Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Self-administered Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Self-administered Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Self-administered Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Self-administered Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Self-administered Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Self-administered Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Self-administered Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Self-administered Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Self-administered Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Self-administered Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Self-administered Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Self-administered Drugs Sales, (K MT), 2023-2028
Table 46. Abbott Laboratories Corporate Summary
Table 47. Abbott Laboratories Self-administered Drugs Product Offerings
Table 48. Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Bristol-Myers Squibb Corporate Summary
Table 50. Bristol-Myers Squibb Self-administered Drugs Product Offerings
Table 51. Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Novartis AG Corporate Summary
Table 53. Novartis AG Self-administered Drugs Product Offerings
Table 54. Novartis AG Self-administered Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Eli Lilly and Company Corporate Summary
Table 56. Eli Lilly and Company Self-administered Drugs Product Offerings
Table 57. Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Gilead Sciences Corporate Summary
Table 59. Gilead Sciences Self-administered Drugs Product Offerings
Table 60. Gilead Sciences Self-administered Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Antares Pharma Corporate Summary
Table 62. Antares Pharma Self-administered Drugs Product Offerings
Table 63. Antares Pharma Self-administered Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Self-administered Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 65. Global Self-administered Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Self-administered Drugs Production by Region, 2017-2022 (K MT)
Table 67. Global Self-administered Drugs Production by Region, 2023-2028 (K MT)
Table 68. Self-administered Drugs Market Opportunities & Trends in Global Market
Table 69. Self-administered Drugs Market Drivers in Global Market
Table 70. Self-administered Drugs Market Restraints in Global Market
Table 71. Self-administered Drugs Raw Materials
Table 72. Self-administered Drugs Raw Materials Suppliers in Global Market
Table 73. Typical Self-administered Drugs Downstream
Table 74. Self-administered Drugs Downstream Clients in Global Market
Table 75. Self-administered Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Self-administered Drugs Segment by Type
Figure 2. Self-administered Drugs Segment by Application
Figure 3. Global Self-administered Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Self-administered Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Self-administered Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Self-administered Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Self-administered Drugs Revenue in 2021
Figure 9. By Type - Global Self-administered Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Self-administered Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Self-administered Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Self-administered Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Self-administered Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Self-administered Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Self-administered Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Self-administered Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Self-administered Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Self-administered Drugs Sales Market Share, 2017-2028
Figure 19. US Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Self-administered Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Self-administered Drugs Sales Market Share, 2017-2028
Figure 24. Germany Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Self-administered Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Self-administered Drugs Sales Market Share, 2017-2028
Figure 33. China Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Self-administered Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Self-administered Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Self-administered Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Self-administered Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Self-administered Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Self-administered Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Self-administered Drugs by Region, 2021 VS 2028
Figure 50. Self-administered Drugs Industry Value Chain
Figure 51. Marketing Channels